Table 2.
Post-transplant characteristics of the entire cohort and divided by long and short hospital stay groups.
| Entire cohort, N = 85 | Long hospital stay group, (L) N = 43 | Short hospital stay group (S), N = 42 | p Value* | |
|---|---|---|---|---|
| Length of stay for SLKT admission, days, me\dian (IQR) | 15.0 (9.0, 30.0) | 30.0 (21.0, 52.0) | 8.5 (7.0, 11.0) | <.001 |
| Duration from admission to transplantation, days, median (IQR) | 1.0 (1.0, 6.0) | 6.0 (1.0, 16.0) | 0 (0, 1.0) | <.001 |
| Duration from transplantation to discharge, days, median (IQR) | 11.0 (8.0, 21.0) | 21.0 (12.0, 42.0) | 8.0 (6.0, 10.0) | <.001 |
| Delayed graft function (kidney), n (%) | 15 (17.6) | 12 (27.9) | 3 (7.1) | .012 |
| Primary non-function (kidney), n (%) | 0 | 0 | 0 | – |
| Death during hospitalization, n (%) | 9 (10.6) | 7 (16.3) | 2 (4.8) | .084 |
| First discharge destination, n (%) | .001 | |||
| Home | 41 (48.2) | 12 (27.9) | 29 (69.0) | |
| Home and taking health service | 22 (25.9) | 13 (30.2) | 9 (21.4) | |
| Rehabilitation hospital | 12 (14.1) | 10 (23.3) | 2 (4.8) | |
| Others | 10 (11.8) | 8 (18.6) | 2 (4.8) | |
| Incidence of developing of de novo DSA, n (%) | 8 (9.4) | 8 (18.6) | 0 | .003 |
| Duration from transplant to measurement of de novo DSA, days, median (IQR) | 53.0 (14.0, 280.5) | 53.0 (14.0, 280.5) | N/A | – |
| Prevalence of any post-transplant DSA, n (%) | 12 (14.1) | 11 (25.6) | 1 (2.4) | .002 |
DSA: Donor specific antibody; IQR: Interquartile range; SLKT: Simultaneous liver–kidney transplantation.
*Compared between long hospital stay and short hospital stay groups. p values for continuous variables with median (IQR) are result of Mann–Whitney test and categorical variables are chi-square test.